Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Amino Acids and Derivatives >  Glutamic acid derivatives >  glycyl-prolyl-glutamic acid

glycyl-prolyl-glutamic acid

Basic information Safety Supplier Related

glycyl-prolyl-glutamic acid Basic information

Product Name:
glycyl-prolyl-glutamic acid
Synonyms:
  • glycyl-prolyl-glutamic acid
  • SC-252859
  • L-GlutaMic acid, glycyl-L-prolyl-
  • Glypromate
  • Gly-Pro-Glu >=98% (HPLC)
  • Glycyl-L-prolyl-L-glutamic acid
  • glycyl-prolyl-glutamic acid USP/EP/BP
  • Gly-Pro-Glu, CAS 32302-76-4
CAS:
32302-76-4
MF:
C12H19N3O6
MW:
301.3
Mol File:
32302-76-4.mol
More
Less

glycyl-prolyl-glutamic acid Chemical Properties

Boiling point:
675.7±55.0 °C(Predicted)
Density 
1.431±0.06 g/cm3(Predicted)
storage temp. 
Store at 0°C
solubility 
H2O: >5mg/mL
form 
white powder
pka
3.51±0.10(Predicted)
color 
White to off-white
More
Less

Safety Information

WGK Germany 
3
More
Less

glycyl-prolyl-glutamic acid Usage And Synthesis

Uses

Gly-Pro-Glu is a neuroactive peptide with a potent action on acetylcholine release. Gly-Pro-Glu is the N-terminal tripeptide of insulin-like growth factor-I. Gly-Pro-Glu inhibits glutamate binds to N-methyl-D-aspartate (NMDA) receptor with an IC50 value of 14.7 μM. Gly-Pro-Glu can be used for the research of neuroprotection [1][2].

Definition

ChEBI: Gly-Pro-Glu is an oligopeptide.

Biological Activity

Gly-Pro-Glu (GPE) is a neuroactive peptide and prevents the binding of glutamate to N-methyl-D-aspartate (NMDA) receptor. It positively regulates the potassium-mediated release of acetylcholine from r at cortical slices. Thus, it is involved in the control of brain function. In vitro studies show th at this peptide confers neuroprotection to CA1-2 hippocampal neurons against excitotoxic insult.', 'Gly-Pro-Glu is a neuroprotective compound and the N-terminal tripeptide of IGF-1. Gly-Pro-Glu is neuroprotective after central administration in animal models of neurodegenerative processes, such as Huntington′s, Parkinson′s, Alzheimer′s diseases, and varies acute brain injury animal models. The neuroprotective activity is not related to its affinity to glutamate receptor. Findings indicate th at GPE mimics insulin-like growth factor I effects on the somatostatin system through a mechanism independent of β-amyloid clearance th at involves modulation of calcium and glycogen synthase kinase 3β signaling.

in vivo

Gly-Pro-Glu (300 mg; i.p. once per day; on day 0, 6 and 12) shows an in vivo effect protecting the temporal cortical somatostatinergic system from Abeta insult.[2].

Animal Model:Ovariectomized rats with Abeta25-35 injection[2]
Dosage:300 mg
Administration:Intraperitoneal injection; 300 mg per day; on day 0, 6 and 12
Result:Recovered Abeta25-35-induced the reduction of somatostatin (SRIF) content and SRIF receptor density, and reduced the inhibitory effect of SRIF on adenylyl cyclase activity.

References

[1] Sara VR, et al. Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide. Biochem Biophys Res Commun. 1989 Dec 15;165(2):766-71. DOI:10.1016/s0006-291x(89)80032-4
[2] Aguado-Llera D, et al. Gly-Pro-Glu protects beta-amyloid-induced somatostatin depletion in the rat cortex. Neuroreport. 2004 Aug 26;15(12):1979-82. DOI:10.1097/00001756-200408260-00029

glycyl-prolyl-glutamic acidSupplier

Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399 18927568969
Email
isunpharm@qq.com
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Nanjing Leon Biological Technology Co., Ltd.
Tel
17705183659
Email
sales@njleonbiotech.com